Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?

被引：0
|
作者：
Michael Hölzel
Anton Bovier
Thomas Tüting
机构：
[1] Michael Hlzel is at the Unit for RNA Biology,Department of Clinical Chemistry and Clinical Pharmacology
[2] University of Bonn,Department of Dermatology and Allergy
[3] 53105 Bonn,undefined
[4] Germany.,undefined
[5] Anton Bovier is at the Institute for Applied Mathematics,undefined
[6] University of Bonn,undefined
[7] 53115 Bonn,undefined
[8] Germany.,undefined
[9] Thomas Tüting is at the Laboratory of Experimental Dermatology,undefined
[10] University of Bonn,undefined
[11] 53105 Bonn,undefined
[12] Germany.,undefined
来源：
Nature Reviews Cancer | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Using malignant melanoma as a paradigm, these authors propose that therapy-induced injury to tumour tissue and the resultant inflammation can activate protective and regenerative responses that represent a shared resistance mechanism to different treatments.
引用
收藏
页码：365 / 376
页数：11
相关论文
共 50 条
  • [21] Pluripotent stem cells as source of dendritic cells for immune therapy
    Satoru Senju
    Shinya Hirata
    Yutaka Motomura
    Daiki Fukuma
    Yusuke Matsunaga
    Satoshi Fukushima
    Hidetake Matsuyoshi
    Yasuharu Nishimura
    International Journal of Hematology, 2010, 91 : 392 - 400
  • [22] Pluripotent stem cells as source of dendritic cells for immune therapy
    Senju, Satoru
    Hirata, Shinya
    Motomura, Yutaka
    Fukuma, Daiki
    Matsunaga, Yusuke
    Fukushima, Satoshi
    Matsuyoshi, Hidetake
    Nishimura, Yasuharu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (03) : 392 - 400
  • [23] Intratumor heterogeneity characterizes immune resistance to adoptive T cell therapy
    Hinohara, Kunihiko
    Nishikawa, Hiroyoshi
    CANCER SCIENCE, 2021, 112 : 178 - 178
  • [24] Assessment of immune cell heterogeneity in the tumour microenvironment
    Brennan, L.
    Brouwer-Visser, J.
    Karpova, M.
    Heller, A.
    Gaire, F.
    Nuesch, E.
    Korski, K.
    Gomes, B.
    VIRCHOWS ARCHIV, 2020, 477 : S204 - S204
  • [25] CHD-loss promotes tumor heterogeneity, lineage plasticity and resistance to AR targeted therapy resistance
    Mu, P.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S22 - S23
  • [26] Unravelling tumour heterogeneity—implications for therapy
    David A. Reardon
    Patrick Y. Wen
    Nature Reviews Clinical Oncology, 2015, 12 : 69 - 70
  • [27] Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance
    Ahmed, Farzana
    Haass, Nikolas K.
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [28] Implications of tumour heterogeneity on cancer evolution and therapy resistance: lessons from breast cancer
    Thakur, Shefali
    Haider, Syed
    Natrajan, Rachael
    JOURNAL OF PATHOLOGY, 2023, : 621 - 636
  • [29] Persister cell plasticity in tumour drug resistance
    Mcdonald, Paul C.
    Dedhar, Shoukat
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2024, 156 : 1 - 10
  • [30] Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression
    Fabiana Lüönd
    Stefanie Tiede
    Gerhard Christofori
    British Journal of Cancer, 2021, 125 : 164 - 175
12345